Meconium-stained amniotic fluid: discharge vigorous newborns

Arch Dis Child Fetal Neonatal Ed. 2010 Jan;95(1):F69-71. doi: 10.1136/adc.2008.150425. Epub 2009 Apr 23.

Abstract

Background: Most infants born through meconium-stained amniotic fluid (MSAF) are observed clinically for 24 h postnatally. Only 5% of infants born through MSAF develop the meconium aspiration syndrome (MAS), a serious condition requiring medical intervention.

Objective: To evaluate the value of 24-h postnatal observation of infants born through MSAF.

Methods: A cohort of 394 term neonates born through MSAF was studied. Data were collected on Apgar scores, the development of MAS and other perinatal factors.

Results: Nineteen of the 394 (4.8%) infants born through MSAF developed MAS. 298 (76%) infants had a 5-minute Apgar score (5'AS) of >or=9. In this group the number of infants developing MAS (1; 0.3%) was significantly lower compared with the 5'AS <or=8 group (18; 19%).

Conclusion: MAS develops rarely in infants born through MSAF with 5'AS above 8. These infants can be safely discharged from the hospital shortly after birth.

Publication types

  • Evaluation Study

MeSH terms

  • Amniotic Fluid*
  • Apgar Score
  • Cohort Studies
  • Female
  • Humans
  • Infant, Newborn
  • Male
  • Meconium Aspiration Syndrome / diagnosis
  • Meconium Aspiration Syndrome / epidemiology*
  • Meconium*
  • Netherlands
  • Patient Discharge*
  • Perinatal Care / methods*
  • Pregnancy